Educational application for visualization and analysis of electric field strength in multiple electrode electroporation

BMC Medical Education

Damijan Miklavčič¹  Tadej Kotnik¹  Samo Mahnič-Kalamiza¹ 

[1] Faculty of Electrical Engineering, University of Ljubljana, Tr&2;aška 25, Ljubljana, SI-1000, Slovenia

关键词: Interactive learning environments;    Interdisciplinary projects;    Applications in subject areas;    Electromagnetic field visualization;    Education on electroporation;   

Others  :  1153203
DOI  :  10.1186/1472-6920-12-102

 received in 2012-06-23, accepted in 2012-10-25,  发布年份 2012

【 摘 要 】

Background

Electrochemotherapy is a local treatment that utilizes electric pulses in order to achieve local increase in cytotoxicity of some anticancer drugs. The success of this treatment is highly dependent on parameters such as tissue electrical properties, applied voltages and spatial relations in placement of electrodes that are used to establish a cell-permeabilizing electric field in target tissue. Non-thermal irreversible electroporation techniques for ablation of tissue depend similarly on these parameters. In the treatment planning stage, if oversimplified approximations for evaluation of electric field are used, such as U/d (voltage-to-distance ratio), sufficient field strength may not be reached within the entire target (tumor) area, potentially resulting in treatment failure.

Results

In order to provide an aid in education of medical personnel performing electrochemotherapy and non-thermal irreversible electroporation for tissue ablation, assist in visualizing the electric field in needle electrode electroporation and the effects of changes in electrode placement, an application has been developed both as a desktop- and a web-based solution. It enables users to position up to twelve electrodes in a plane of adjustable dimensions representing a two-dimensional slice of tissue. By means of manipulation of electrode placement, i.e. repositioning, and the changes in electrical parameters, the users interact with the system and observe the resulting electrical field strength established by the inserted electrodes in real time. The field strength is calculated and visualized online and instantaneously reflects the desired changes, dramatically improving the user friendliness and educational value, especially compared to approaches utilizing general-purpose numerical modeling software, such as finite element modeling packages.

Conclusion

In this paper we outline the need and offer a solution in medical education in the field of electroporation-based treatments, e.g. primarily electrochemotherapy and non-thermal irreversible tissue ablation. We present the background, the means of implementation and the fully functional application, which is the first of its kind. While the initial feedback from students that have evaluated this application as part of an e-learning course is positive, a formal study is planned to thoroughly evaluate the current version and identify possible future improvements and modifications.

【 授权许可】

   
2012 Mahnic-Kalamiza et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

【 参考文献 】

• [1]Neumann E, Schaeferridder M, Wang Y, Hofschneider P: Gene-transfer into mouse lyoma cells by electroporation in high electric-fields. EMBO J 1982, 1:841-845.
• [2]Neumann E, Rosenheck K: Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 1972, 10:279-290.
• [3]Kinosita K, Tsong T: Formation and resealing of pores of controlled sizes in human erythrocyte membrane. Nature 1977, 268:438-441.
• [4]Gurtovenko A, Anwar J, Vattulainen I: Defect-mediated trafficking across cell membranes: Insights from in silico modeling. Chem Rev 2010, 110:6077-6103.
• [5]Rols M: Electropermeabilization, a physical method for the delivery of therapeutic molecules into cells. Biochim Biophys Acta-Biomembr 2006, 1758:423-428.
• [6]Kanduser M, Miklavcic D: Electroporation in Biological Cell and Tissue: An Overview. In Electrotechnologies for Extraction from Food Plants and Biomaterials. Edited by Vorobiev E, Lebovka N. New York: Springer Science+Business Media; 2008:1-37.
• [7]Weaver J: Electroporation: A general phenomenon for manipulating cells and tissues. J Cell Biochem 1993, 51:426-435.
• [8]Rubinsky B, Onik G, Mikus P: Irreversible electroporation: A new ablation modality - clinical implications. Technol Cancer Res Treat 2007, 6:37-48.
• [9]Bouzrara H, Vorobiev E: Beet juice extraction by pressing and pulsed electric fields. Int Sugar J 2000, 102:194-200.
• [10]Sack M, Sigler J, Frenzel D, Eing C, Arnold J, Michelberger T, Frey W, Attmann F, Stukenbrock L, Mueller G: Research on industrial-scale electroporation devices fostering the extraction of substances from biological tissue. Food Eng Rev 2010, 2:147-156.
• [11]Castro A, Barbosacanovas G, Swanson B: Microbial inactivation of foods by pulsed electric-fields. J Food Process Preserv 1993, 17:47-73.
• [12]Miklavcic D, Towhidi L: Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells. Radiol Oncol 2010, 44:34-41.
• [13]Orlowski S, Belehradek J, Paoletti C, Mir L: Transient electropermeabilization of cells in culture - increase of the cyto-toxicity of anticancer drugs. Biochem Pharmacol 1988, 37:4727-4733.
• [14]Sersa G, Cemazar M, Miklavcic D: Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(ii) in mice. Cancer Res 1995, 55:3450-3455.
• [15]Tounekti O, Pron G, Belehradek J, Mir L: Bleomycin, an apoptosis-mimetic drug that induces 2 types of cell-death depending on the number of molecules internalized. Cancer Res 1993, 53:5462-5469.
• [16]Mir L, Orlowski S, Belehradek J, Paoletti C: Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 1991, 27:68-72.
• [17]Sersa G, Cemazar M, Snoj M: Electrochemotherapy of tumours. Curr Oncol 2009, 16:118-119.
• [18]Jarm T, Cemazar M, Miklavcic D, Sersa G: Antivascular effects of electrochemotherapy: Implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010, 10:729-746.
• [19]Miklavcic D, Corovic S, Pucihar G, Pavselj N: Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. EJC Suppl 2006, 4:45-51.
• [20]Kos B, Zupanic A, Kotnik T, Snoj M, Sersa G, Miklavcic D: Robustness of Treatment Planning for Electrochemotherapy of Deep-Seated Tumors. J Membr Biol 2010, 236:147-153.
• [21]Corovic S, Al Sakere B, Haddad V, Miklavcic D, Mir L: Importance of contact surface between electrodes and treated tissue in electrochemotherapy. Technol Cancer Res Treat 2008, 7:393-399.
• [22]Ivorra A, Al-Sakere B, Rubinsky B, Mir L: Use of conductive gels for electric field homogenization increases the antitumor efficacy of electroporation therapies. Phys Med Biol 2008, 53:6605-6618.
• [23]Miklavcic D, Semrov D, Mekid H, Mir L: A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta-Gen Subj 2000, 1523:73-83.
• [24]Zupanic A, Corovic S, Miklavcic D: Optimization of electrode position and electric pulse amplitude in electrochemotherapy. Radiol Oncol 2008, 42:93-101.
• [25]Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G: The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 1998, 74:2152-2158.
• [26]Mir L, Gehl J, Sersa G, Collins C, Garbay J-R, Billard V, Geertsen P, Rudolf Z, O’Sullivan G, Marty M: Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. EJC Suppl 2006, 4:14-25.
• [27]Mahmood F, Gehl J: Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. Bioelectrochemistry 2011, 81:10-16.
• [28]Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, Mali B, Jarm T, Pavliha D, Marcan M, Gasljevic G, Gorjup V, Music M, Vavpotic TP, Cemazar M, Snoj M, Sersa G: Electrochemotherapy: A New Technological Approach in Treatment of Metastases in the Liver RID B-9396-2008. Technol Cancer Res Treat 2011, 10:475-485.
• [29]Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, Bracko M, Pecnik T, Gadzijev E, Sersa G: Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 2010, 9:10. BioMed Central Full Text
• [30]Pavliha D, Kos B, Zupanic A, Marčan M, Serša G, Miklavčič D: Patient-specific treatment planning of electrochemotherapy: Procedure design and possible pitfalls. Bioelectrochemistry 2012, 87:265-273.
• [31]Sano M, Neal R, Garcia P, Gerber D, Robertson J, Davalos R: Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. Biomed Eng Online 2010, 9:31. BioMed Central Full Text
• [32]Edd J, Horowitz L, Davalos R, Mir L, Rubinsky B: In vivo results of a new focal tissue ablation technique: Irreversible electroporation. IEEE Trans Biomed Eng 2006, 53:1409-1415.
• [33]Rubinsky B: Irreversible electroporation in medicine. Tech Canc Res Treat 2007, 6:255-259.
• [34]Rempp H, Boss A, Helmberger T, Pereira P: The current role of minimally invasive therapies in the management of liver tumors. Abdom Imaging 2011, 36:635-647.
• [35]Sel D, Mazeres S, Teissie J, Miklavcic D: Finite-element modeling of needle electrodes in tissue from the perspective of frequent model computation. IEEE Trans Biomed Eng 2003, 50:1221-1232.
• [36]Sersa G, Gehl J, Garbay J-R, Soden D, O’Sullivan G, Matthiessen L, Snoj M, Mir L: Electrochemotherapy of small tumors: the experience from the ESOPE (European Standard Operating Procedures for Electrochemotherapy) group. New York: Springer; 2011:93-102. [Clinical aspects of electroporation]
• [37]Magjarevic R, Lackovic I, Miklavcic D: Pet godina šire primjene elektrokemoterapije u klinici. Liječničke novine 2011, 97:36-39.
• [38]Pech M, Janitzky A, Wendler J, Strang C, Blaschke S, Dudeck O, Ricke J, Liehr U-B: Irreversible electroporation of renal cell carcinoma: A first-in-man phase I clinical study. Cardiovasc Interv Radiol 2011, 34:132-138.
• [39]Onik G, Rubinsky B: Irreversible Electroporation: First Patient Experience Focal Therapy of Prostate Cancer. In Irreversible Electroporation. Edited by Rubinsky B. Berlin Heidelberg: Springer; 2010:235-247.
• [40]Corovic S, Bester J, Miklavcic D: An e-learning application on electrochemotherapy. Biomed Eng Online 2009, 8:26. BioMed Central Full Text
• [41]Sinigoj A: Osnove elektromagnetike. Ljubljana: Fakulteta za elektrotehniko; 2002.
• [42]Dev S, Dhar D, Krassowska W: Electric field of a six-needle array electrode used in drug and DNA delivery in vivo: Analytical versus numerical solution. IEEE Trans Biomed Eng 2003, 50:1296-1300.
• [43]Corovic S, Pavlin M, Miklavcic D: Analytical and numerical quantification and comparison of the local electric field in the tissue for different electrode configurations. Biomed Eng Online 2007, 6:23. BioMed Central Full Text
• [44]Bergues Pupo AE, Bory Reyes J, Bergues Cabrales LE, Bergues Cabrales JM: Analytical and numerical solutions of the potential and electric field generated by different electrode arrays in a tumor tissue under electrotherapy. Biomed Eng Online 2011, 10:85. BioMed Central Full Text
• [45]Rebersek M, Miklavcic D: Advantages and disadvantages of different concepts of electroporation pulse generation. Automatika 2011, 52:12-19.
• [46]Pucihar G, Krmelj J, Rebersek M, Napotnik T, Miklavcic D: Equivalent pulse parameters for electroporation. IEEE Trans Biomed Eng 2011, 58:3279-3288.
• [47]Sun P-C, Tsai R, Finger G, Chen Y, Yeh D: What drives a successful e-Learning? An empirical investigation of the critical factors influencing learner satisfaction. Comput Educ 2008, 50:1183-1202.
• [48]Haemmerich D, Staelin S, Tsai J, Tungjitkusolmun S, Mahvi D, Webster J: In vivo electrical conductivity of hepatic tumours. Physiol Meas 2003, 24:251-260.
• [49]Adeyanaju OO, Al-Angari HM, Sahakian AV: The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma. Radiol Oncol 2012, 46:126-135.
• [50]Lee E, Loh C, Kee S: Imaging guided percutaneous irreversible electroporation: Ultrasound and immunohistological correlation. Technol Cancer Res Treat 2007, 6:287-293.
• [51]Edd J, Davalos R: Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat 2007, 6:275-286.
• [52]Zupanic A, Miklavcic D: Tissue heating during tumor ablation with irreversible electroporation. Elektrotehniški vestnik 2011, 78:42-47.
• [53]Stratton JA: Electromagnetic Theory. New Jersey: John Wiley & Sons; 2007.